Evidence map›Paper›PMID 31222077›Full record

ArticleScientific reports2019

Innovative mouse model mimicking human-like features of spinal cord injury: efficacy of Docosahexaenoic acid on acute and chronic phases.

Sara Marinelli, Valentina Vacca, Federica De Angelis, Luisa Pieroni, Tiziana Orsini, Chiara Parisi, Marzia Soligo, Virginia Protto, Luigi Manni, Roberto Guerrieri and 1 more

Erratum issuedOpen access · goldAbstract read
In one paragraph

Article in Scientific reports, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
1.4field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 28 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. XeominToxins · 2023
    Article
  9. Review
  10. Article
  11. Article
  12. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

11 authors at 4 institutions in 1 country.

Sara MarinelliCNR - National Research Council, Institute of Cell Biology and Neurobiology, 00015, Monterotondo Scalo, Italy.ORCID http://orcid.org/0000-0001-5393-4796
Valentina VaccaCNR - National Research Council, Institute of Cell Biology and Neurobiology, 00015, Monterotondo Scalo, Italy.
Federica De AngelisIRCCS - Santa Lucia Foundation, 00143, Roma, Italy.
Luisa PieroniIRCCS - Santa Lucia Foundation, 00143, Roma, Italy.
Tiziana OrsiniCNR - National Research Council, Institute of Cell Biology and Neurobiology, 00015, Monterotondo Scalo, Italy.
Chiara ParisiCNR - National Research Council, Institute of Cell Biology and Neurobiology, 00015, Monterotondo Scalo, Italy.
Marzia SoligoCNR - National Research Council, Institute of Translational Pharmacology, 00133, Roma, Italy.
Virginia ProttoCNR - National Research Council, Institute of Translational Pharmacology, 00133, Roma, Italy.
Luigi ManniCNR - National Research Council, Institute of Translational Pharmacology, 00133, Roma, Italy.
Roberto GuerrieriDepartment of Electrical, Electronic, and Information Engineering «Guglielmo Marconi», University of Bologna, 40136, Bologna, Italy.
Flaminia PavoneCNR - National Research Council, Institute of Cell Biology and Neurobiology, 00015, Monterotondo Scalo, Italy. flaminia.pavone@cnr.it.
Fondazione Santa Lucia · ITIstituto di Farmacologia Traslazionale · ITNational Research Council · ITMarconi University · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Traumatic spinal cord injury has dramatic consequences and a huge social impact. We propose a new mouse model of spinal trauma that induces a complete paralysis of hindlimbs, still observable 30 days after injury. The contusion, performed without laminectomy and deriving from the pressure exerted directly on the bone, mimics more closely many features of spinal injury in humans. Spinal cord was injured at thoracic level 10 (T10) in adult anesthetized female CD1 mice, mounted on stereotaxic apparatus and connected to a precision impactor device. Following severe injury, we evaluated motor and sensory functions, and histological/morphological features of spinal tissue at different time points. Moreover, we studied the effects of early and subchronic administration of Docosahexaenoic acid, investigating functional responses, structural changes proximal and distal to the lesion in primary and secondary injury phases, proteome modulation in injured spinal cord. Docosahexaenoic acid was able i) to restore behavioural responses and ii) to induce pro-regenerative effects and neuroprotective action against demyelination, apoptosis and neuroinflammation. Considering the urgent health challenge represented by spinal injury, this new and reliable mouse model together with the positive effects of docosahexaenoic acid provide important translational implications for promising therapeutic approaches for spinal cord injuries.

Indexed as

Disease Models, AnimalAcute DiseaseAnimalsChronic DiseaseDocosahexaenoic AcidsFemaleHumansMiceSpinal Cord InjuriesDocosahexaenoic Acids

Identifiers

PMID31222077
PMCPMC6586623
OpenAlexW2951092226

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.